Citizens Downgrades Kalvista Pharmaceuticals Inc (KALV) to Market Perform
Tweet
Share
E-mailGet Alerts KALV Hot Sheet
Price: $26.95 +0.04%
Rating Summary:
7 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Rating Summary:
7 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Join SI Premium – FREE
Citizens analyst Jonathan Wolleben downgraded Kalvista Pharmaceuticals Inc (NASDAQ: KALV) from Market Outperform to Market Perform.
For an analyst ratings summary and ratings history on Kalvista Pharmaceuticals Inc click here. For more ratings news on Kalvista Pharmaceuticals Inc click here.
Shares of Kalvista Pharmaceuticals Inc closed at $19.24 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bernstein SocGen Group Starts Terawulf Inc. (WULF) at Outperform
- Bitmine Immersion Technologies plans $300 million preferred stock offering
- Greenway Technologies board member Raymond Wright resigns
Create E-mail Alert Related Categories
DowngradesRelated Entities
Citi, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
